Acute Coronary Syndrome, Coronary Disease, Myocardial Infarction, Unstable Angina Pectoris
Conditions
Keywords
Acute Coronary Syndrome, Eastern Europe, Therapies
Brief summary
The International Registry of Acute Coronary Syndromes registry study (ISACS) is both a retrospective and prospective study which was designed in order to obtain data of patients with acute coronary syndromes, and herewith control and optimize internationally guideline-recommended therapies in these countries
Detailed description
Aims of this survey study are (1) documentation of the characteristics of all patients presenting to the ISACS centers with STEMI or NSTEMI (2) documentation of in-hospital outcome, and outcome rates at 6 month and 1 year, (3) documentation of invasive procedures and procedure-associated complications (4) documentation of therapeutic regimens and investigation conformity of treatment with already established guidelines. Investigators: ISACS Administrative Committee: Raffaele Bugiardini (Italy-Principal Investigator) Lina Badimon (Spain) Olivia Manfrini (Italy- Project Coordinator) Edina Cenko (Italy-Center Coordinator) Steering Committee: Mirza Dilic (Bosnia and Herzegovina), Asen Goudev (Bulgaria), Davor Milicic (Croatia), Raffaele Bugiardini, Edina Cenko and Olivia Manfrini (Italy) Gani Bajraktari (Kosovo), Andrejs Erglis and Ilja Zakke (Latvia), Remigius Zaliunas and Olivija Gustiene (Lithuania), Sasko Kedev and Marija Vavlukis (North Macedonia), Mihail Popovici (Moldova), Maria Dorobantu (Romania), Zorana Vasiljevic (Serbia), Eva Goncalvesova and Martin Studenkan (Slovakia) , Alexander N. Parkhomenko (Ukraine) , Christopher P Gale (United Kingdom).
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* acute coronary syndromes
Exclusion criteria
* under age or not able to give informed consent
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| All causes mortality | 30 days, 6 months, 1 year | All causes mortality |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Cardiovascular mortality | 30 days, 6 months, 1 year | Cardiovascular mortality |
| Recurrent myocardial infarction | 30 days, 6 months, 1year | Recurrent myocardial infarction |
| Pharmacogenetic and cardiovascular genetic studies associated to clinical outcomes | 6 month, 1 year | Pharmacogenetic and cardiovascular genetic studies associated to clinical outcomes |
| Adherence to internationally guideline recommended therapies across the participating countries | discharge, 6 months, 1 year | Adherence to internationally guideline recommended therapies across the participating |
Countries
Italy